Skip to content
Life Sciences Seed Founded 2023

Log10

Everest by Log10 is an agentic AI platform for life sciences that powers regulatory, clinical, and commercial workflows for pharmaceutical companies, medtech firms, and CROs. The platform turns source files into submission-ready documents in minutes, generating not just the document but the underlying statistical analysis including TLFs and reproducible R and SAS code. Everest supports every phase of clinical trials…

📍 San Francisco, United States · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeed
Amount$7M
Date29 April 2024
Total raised$7M
Team size13

About

Everest by Log10 is an agentic AI platform for life sciences that powers regulatory, clinical, and commercial workflows for pharmaceutical companies, medtech firms, and CROs. The platform turns source files into submission-ready documents in minutes, generating not just the document but the underlying statistical analysis including TLFs and reproducible R and SAS code. Everest supports every phase of clinical trials from study startup through regulatory submission, handling protocols, investigator brochures, clinical study reports, and drug applications. The platform is SOC 2 Type II and HIPAA compliant with zero data retention from LLM providers, offering enterprise-grade security with optional VPC deployment and enhanced data isolation. Founded in 2023, headquartered in San Francisco, United States, The company has raised $7.2M at the Seed stage, backed by investors including TQ Ventures, Quiet Capital, Essence VC..

Team background

Company Wise > Intel

Institutional investors

TQ Ventures Quiet Capital Essence VC

Latest coverage

No articles yet.

Raising like Log10?

Analyze your pitch deck before your next raise.

Analyze My Deck →